New drug targets Hard-to-Treat cancers with genetic weakness

NCT ID NCT07109726

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new drug, TER-2013, in people with advanced solid tumors (like breast, ovarian, or lung cancer) that have specific genetic changes in the AKT/PI3K/PTEN pathway. The goal is to see if the drug is safe and can shrink tumors. About 205 participants will receive the drug, and researchers will monitor side effects and how well the cancer responds.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Carolina BioOncology Institute

    RECRUITING

    Huntersville, North Carolina, 28078, United States

    Contact Email: •••••@•••••

  • Florida Cancer Specialists - Lake Nona

    RECRUITING

    Orlando, Florida, 32827, United States

  • Froedtert & MCW Cancer Center

    RECRUITING

    Milwaukee, Wisconsin, 53226, United States

  • MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

  • Massachusetts General Hospital

    RECRUITING

    Boston, Massachusetts, 02144, United States

  • Mayo Rochester

    RECRUITING

    Rochester, Minnesota, 55905, United States

    Contact Email: •••••@•••••

  • NEXT Oncology

    RECRUITING

    Austin, Texas, 78229, United States

  • NEXT Oncology

    RECRUITING

    Fairfax, Virginia, 22031, United States

  • Nebraska Cancer Specialists

    RECRUITING

    Omaha, Nebraska, 68130, United States

  • PanOncology Trials

    RECRUITING

    San Juan, 00935, Puerto Rico

    Contact Email: •••••@•••••

  • START Center for Cancer Research

    RECRUITING

    San Antonio, Texas, 78229, United States

  • START Center for Cancer Research

    RECRUITING

    West Valley City, Utah, 84119, United States

  • Sarah Cannon Nashville

    RECRUITING

    Nashville, Tennessee, 37203, United States

  • UH Cleveland Medical Center

    RECRUITING

    Cleveland, Ohio, 44106, United States

  • Washington Univ. School of Medicine

    RECRUITING

    St Louis, Missouri, 63110, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.